Award
NIH Reporter #5R01DA060228-02
Discovery of GPR52 ligand probes for cocaine use disorder
Recipient
UNIVERSITY OF TEXAS MED BR GALVESTON
Award Amount
$795,090.00
Ceiling
$795,090.00
Awarded
May 26, 2026
Identifier
5R01DA060228-02
This award funds research to create and evaluate novel small molecule activators of the brain receptor GPR52 as potential treatments for cocaine use disorder, addressing a significant health problem with no current medication-assisted therapy.
Description
The project aims to develop and evaluate GPR52 receptor ligands as potential therapeutics for cocaine use disorder. The award is managed by the National Institute on Drug Abuse, part of NIH. The project involves preclinical studies and drug development.